Recursion Pharmaceuticals vs Regeneron Pharmaceuticals

Side-by-side comparison of AI visibility scores, market position, and capabilities

Regeneron Pharmaceuticals leads in AI visibility (79 vs 57)
Recursion Pharmaceuticals logo

Recursion Pharmaceuticals

ChallengerHealthcare Tech

AI Drug Discovery / Computational Biology

Public AI drug discovery platform (NASDAQ: RXRX). 5 clinical programs. Merged with Exscientia ($688M). 2025 rev $74.7M. $755M cash. Founded 2013, Salt Lake City.

AI VisibilityBeta
Overall Score
C57
Category Rank
#156 of 596
AI Consensus
72%
Trend
stable
Per Platform
ChatGPT
57
Perplexity
61
Gemini
54

About

Recursion Pharmaceuticals (NASDAQ: RXRX) is a computational biology company industrializing drug discovery with AI, founded in 2013 in Salt Lake City, Utah. Built Recursion OS, a vertically integrated platform unifying biology, chemistry, and clinical development. Completed $688M all-stock Exscientia merger (November 2024). Market cap ~$1.62B.

Full profile
Regeneron Pharmaceuticals logo

Regeneron Pharmaceuticals

LeaderHealthcare Tech

Enterprise

Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.

AI VisibilityBeta
Overall Score
B79
Category Rank
#30 of 596
AI Consensus
73%
Trend
stable
Per Platform
ChatGPT
77
Perplexity
76
Gemini
75

About

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.

Full profile

AI Visibility Head-to-Head

57
Overall Score
79
#156
Category Rank
#30
72
AI Consensus
73
stable
Trend
stable
57
ChatGPT
77
61
Perplexity
76
54
Gemini
75
52
Claude
85
63
Grok
74

Key Details

Category
AI Drug Discovery / Computational Biology
Enterprise
Tier
Challenger
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Recursion Pharmaceuticals
AI Drug Discovery / Computational Biology

Integrations

Only Recursion Pharmaceuticals
Only Regeneron Pharmaceuticals
Recursion Pharmaceuticals is classified as company. Regeneron Pharmaceuticals is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.